Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1962 1
1963 1
1965 1
1966 2
1967 2
1968 4
1969 1
1970 1
1972 1
1973 1
1974 5
1975 6
1976 5
1977 2
1978 3
1979 1
1981 5
1982 2
1983 3
1984 10
1985 15
1986 19
1987 23
1988 13
1989 24
1990 19
1991 30
1992 14
1993 15
1994 10
1995 25
1996 14
1997 25
1998 19
1999 14
2000 20
2001 19
2002 29
2003 40
2004 45
2005 42
2006 60
2007 74
2008 78
2009 122
2010 113
2011 123
2012 115
2013 115
2014 148
2015 134
2016 169
2017 145
2018 114
2019 146
2020 212
2021 209
2022 198
2023 194
2024 59

Text availability

Article attribute

Article type

Publication date

Search Results

2,764 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.
Felip E, Altorki N, Zhou C, Csőszi T, Vynnychenko I, Goloborodko O, Luft A, Akopov A, Martinez-Marti A, Kenmotsu H, Chen YM, Chella A, Sugawara S, Voong D, Wu F, Yi J, Deng Y, McCleland M, Bennett E, Gitlitz B, Wakelee H; IMpower010 Investigators. Felip E, et al. Among authors: chen ym. Lancet. 2021 Oct 9;398(10308):1344-1357. doi: 10.1016/S0140-6736(21)02098-5. Epub 2021 Sep 20. Lancet. 2021. PMID: 34555333 Clinical Trial.
Lung Cancer in Republic of China.
Luo YH, Chiu CH, Scott Kuo CH, Chou TY, Yeh YC, Hsu HS, Yen SH, Wu YH, Yang JC, Liao BC, Hsia TC, Chen YM. Luo YH, et al. Among authors: chen ym. J Thorac Oncol. 2021 Apr;16(4):519-527. doi: 10.1016/j.jtho.2020.10.155. J Thorac Oncol. 2021. PMID: 33781442 Free article. No abstract available.
Genome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility.
Xu F, Yu EY, Cai X, Yue L, Jing LP, Liang X, Fu Y, Miao Z, Yang M, Shuai M, Gou W, Xiao C, Xue Z, Xie Y, Li S, Lu S, Shi M, Wang X, Hu W, Langenberg C, Yang J, Chen YM, Guo T, Zheng JS. Xu F, et al. Among authors: chen ym. Nat Commun. 2023 Feb 16;14(1):896. doi: 10.1038/s41467-023-36491-3. Nat Commun. 2023. PMID: 36797296 Free PMC article.
RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
Teng PC, Liang Y, Yarmishyn AA, Hsiao YJ, Lin TY, Lin TW, Teng YC, Yang YP, Wang ML, Chien CS, Luo YH, Chen YM, Hsu PK, Chiou SH, Chien Y. Teng PC, et al. Among authors: chen ym. Int J Mol Sci. 2021 Sep 30;22(19):10592. doi: 10.3390/ijms221910592. Int J Mol Sci. 2021. PMID: 34638933 Free PMC article. Review.
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice.
Le X, Sakai H, Felip E, Veillon R, Garassino MC, Raskin J, Cortot AB, Viteri S, Mazieres J, Smit EF, Thomas M, Iams WT, Cho BC, Kim HR, Yang JC, Chen YM, Patel JD, Bestvina CM, Park K, Griesinger F, Johnson M, Gottfried M, Britschgi C, Heymach J, Sikoglu E, Berghoff K, Schumacher KM, Bruns R, Otto G, Paik PK. Le X, et al. Among authors: chen ym. Clin Cancer Res. 2022 Mar 15;28(6):1117-1126. doi: 10.1158/1078-0432.CCR-21-2733. Clin Cancer Res. 2022. PMID: 34789481 Free PMC article. Clinical Trial.
2,764 results